Amino acids are widely valued in the pharmaceutical excipients field due to their natural origin, safety, and functional versatility. They can improve the solubility, stability, and bioavailability of drugs. For instance, glutamic acid and lysine are commonly used as buffering agents to adjust drug pH, enhancing formulation stability. Glycine and serine are employed to increase the solubility of injectables. Certain amino acids also serve as excipients themselves, such as leucine, which acts as a tablet lubricant to ensure formulation flowability and uniformity. Additionally, amino acid derivatives like acetylcysteine are used for mucus dissolution, widely applied in the treatment of respiratory diseases. Non-natural amino acids can further modify drug molecules, improving their targeting and therapeutic efficacy. The multifunctionality of amino acids makes them critical materials in the pharmaceutical excipient sector, playing significant roles in solid, liquid, and biological formulations.
Pharmaceutical excipients are auxiliary substances and carriers used in drug production and formulation, excluding active pharmaceutical ingredients (APIs). These materials undergo rigorous safety evaluations and are incorporated into drug formulations. Excipients enhance API stability, facilitate various dosage forms, act as carriers, and serve as solubilizers and controlled-release agents. They play vital roles in improving solubility, permeability, and release control, making them essential in the development of solid oral dosage forms. As the pharmaceutical industry advances, the range and applications of excipients continue to expand, particularly in personalized therapies and innovative drug formulations, where excipient innovation is pivotal.
Fig. 1. Amino acids in drug excipients.
The essence of the drug formulation design process lies in selecting different excipients based on various dosage forms. Excipients are the foundational materials and essential components of pharmaceutical formulations. The purposes of using excipients include the following:
Amino acid-based pharmaceutical excipients refer to excipients derived from amino acid structures that perform various functions in drug formulations. These functions include improving drug stability, solubility, controlled release, and enhancing bioavailability. Amino acid excipients are widely used not only in protein drugs, peptide drugs, and other biologics but also in formulation design, clinical therapies, and personalized medicine development, where their importance is steadily increasing. For instance, amino acids can act as solvent additives for protein purification and stabilizers in protein formulations. Amino acids such as glycine and arginine can enhance the long-term stability of proteins through mechanisms like preferential hydration, direct binding, pH buffering, or antioxidant properties. Furthermore, amino acid excipients play a significant role in controlled-release systems by regulating drug release rates. Certain amino acids, due to their specific hydrophilic or hydrophobic properties, can form colloids or sustained-release matrices in the body, prolonging drug release and enabling long-term therapeutic effects.
BOC Sciences offers a comprehensive range of natural and non-natural amino acids, including common varieties such as glycine, glutamic acid, and leucine, as well as functional amino acid derivatives. These products meet diverse application needs in pharmaceutical formulations. Equipped with advanced production facilities and strict adherence to cGMP standards, BOC Sciences ensures product quality and consistency. Additionally, we provide professional custom synthesis services to develop specific amino acid products tailored to client requirements, optimizing their functional properties in drug applications.
Name | CAS | Catalog | Price |
L-Arginine hydrochloride | 1119-34-2 | BAT-008148 | Inquiry |
L-methionine | 63-68-3 | BAT-014309 | Inquiry |
L-Tyrosine | 60-18-4 | BAT-014313 | Inquiry |
L-Cysteine | 52-90-4 | BAT-008087 | Inquiry |
L-Threonine | 72-19-5 | BAT-014311 | Inquiry |
L-Alanine | 56-41-7 | BAT-014294 | Inquiry |
Excipients come in a wide variety and can be broadly classified based on their specific functions in pharmaceutical formulations. Each type of excipient serves a distinct role to ensure smooth production processes and optimal therapeutic effects for patients. Below are the primary categories of excipients:
Diluents are excipients used to increase the bulk of a pharmaceutical formulation, primarily in solid dosage forms such as tablets and capsules. They facilitate manufacturing processes and improve patient handling and consumption. Typically inert substances, they do not affect the pharmacological action of the drug. Common diluents include lactose, microcrystalline cellulose, starch, and polyvinyl alcohol. The choice of diluent depends on factors such as the drug's stability, solubility, flowability, and cost. For example, lactose is widely used in tablet and capsule production due to its excellent compressibility and solubility, while microcrystalline cellulose, a commonly used diluent, enhances drug stability and dissolution rates.
Binders are essential excipients that hold drug particles together to form granules or solid structures, providing the fundamental framework for pharmaceutical formulations. They are commonly used in processes like tablet compression and granulation to improve mechanical strength and prevent breakage during manufacturing or transport. Typical binders include hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone (PVP), and hydroxyethyl cellulose (HEC). The selection of a binder often depends on its influence on drug dissolution. Some binders form rigid structures to achieve controlled release, while others facilitate rapid drug disintegration.
Disintegrants ensure that drugs disintegrate quickly in the gastrointestinal tract, accelerating dissolution and absorption. They work by absorbing water or gastric fluids, causing the drug to break into smaller particles and enhancing solubility. Common disintegrants include crospovidone, sodium carboxymethyl starch (CMS), and polyvinyl alcohol (PVA). Disintegrants are crucial for designing fast-release formulations. For example, crospovidone not only accelerates drug disintegration but also improves dissolution rates, ensuring rapid absorption and optimal therapeutic effects.
Lubricants reduce friction between drug particles and equipment during production, facilitating smooth manufacturing processes. They also reduce inter-particle friction, enabling efficient tablet compression or capsule filling. Common lubricants include magnesium stearate, talc, and silicon dioxide. Besides aiding production, lubricants enhance the appearance and handling of the final product. Choosing an appropriate lubricant is critical, as excessive use may hinder drug disintegration and affect efficacy.
Preservatives are used to inhibit microbial growth and prevent contamination during storage and use, particularly in liquid and biological formulations. They are commonly added to oral solutions, injectables, and ophthalmic preparations to ensure sterility and safety. Examples include benzoic acid, sodium chloride, and propylene glycol. The use of preservatives must balance their impact on the drug's active ingredients and their safety. For instance, benzoic acid and its sodium salt are widely used to prevent microbial contamination in liquid formulations, while glycerol acts as a preservative to extend the shelf life of preparations.
Stabilizers extend the shelf life of drugs by preventing degradation during storage. This is particularly important for sensitive drugs such as proteins and biologics that are affected by temperature, humidity, and light. Stabilizers enhance drug stability by inhibiting degradation or minimizing interactions with other components. Common stabilizers include antioxidants (e.g., vitamin C and vitamin E), photostabilizers, and preservatives.
Solvents and dispersing agents are used in liquid formulations to dissolve active ingredients or ensure uniform distribution. Solvents, such as water and alcohols, dissolve the active components, while dispersing agents, like polysorbates (e.g., Tween) and xanthan gum, prevent aggregation or precipitation. These excipients are crucial for ensuring drug solubility and bioavailability, especially for poorly water-soluble drugs, aiding in their absorption in the body.
Emulsifiers stabilize immiscible oil and water components, helping them form a uniform emulsion. They reduce surface tension at the oil-water interface, enabling stable mixing and preventing separation. Common emulsifiers include polysorbates (e.g., Tween) and sodium stearate. Emulsifiers are widely used in the preparation of emulsions, injectables, and topical formulations to ensure uniformity and prevent sedimentation or phase separation.
Diluents | Description |
Starch | Commonly derived from corn starch, a white powder that is odorless and tasteless, insoluble in cold water and ethanol. It has adhesive properties but poor flowability and compressibility. Stable and compatible with most drugs, it offers good appearance and cost-effectiveness, making it a commonly used excipient. |
Sucrose | Colorless crystals or white crystalline powder, odorless, with a sweet taste. Soluble in water but nearly insoluble in ethanol. Stable under room temperature and moderate humidity but unstable under high heat or acidic conditions. Provides strong adhesion, enhancing tablet hardness but with strong hygroscopicity. Adhesive for dry granulation: 2-20%; wet granulation: 50-67%; tablet coating syrup: 50-67%. |
Lactose | Widely used as a filler or diluent and suitable for direct compression. Direct compression lactose offers good flowability and compressibility, often mixed with microcrystalline cellulose or starch. Requires a tablet lubricant like 0.5% magnesium stearate, with lactose content reaching 65-85% in these formulations. |
Pregelatinized Starch | White powder, odorless, tasteless, and soluble in 10-20% cold water but insoluble in ethanol. Offers good flowability, compressibility, and disintegration properties, making it a multifunctional excipient for direct compression. |
Microcrystalline Cellulose | White or off-white powder, odorless, tasteless, with strong binding and compressibility. Suitable for direct compression. Tablets containing over 20% exhibit good disintegration properties. |
Mannitol | White, crystalline powder or granules with a sweet taste, about half as sweet as sucrose. Suitable for chewable and orally disintegrating tablets but relatively expensive. Often used with sucrose and requires a higher proportion of lubricant to prevent sticking during compression. |
Moistening Agents | Description |
Distilled Water | Preferred moistening agent but requires high drying temperatures and long drying times, unsuitable for water-sensitive drugs. In formulations with high water-soluble components, clumping may occur, and granules may harden after drying. |
Ethanol | Used for water-sensitive drugs, typically in ethanol-water mixtures with concentrations of 30-70%. |
Binders | Description |
Starch Paste | Produced by heating starch in water until gelatinization. Corn starch gelatinizes at 73°C. Prepared by either boiling or pouring boiling water over suspended starch while stirring until gelatinized. |
Hydroxypropyl Methylcellulose | White fibrous or granular powder, odorless and tasteless. Swells and dissolves in cold water but not in hot water or ethanol. Soluble in water-ethanol mixtures. Prepared by adding to hot water (80-90°C) and stirring until dissolved upon cooling. |
Hydroxypropyl Cellulose | White or off-white powder, odorless and tasteless. Dissolves in cold water to form a transparent solution and gels when heated. It is slightly hygroscopic and soluble in water and ethanol, available in various viscosity grades, and serves as an excellent binder. |
Methylcellulose | White or off-white fibrous or granular powder, odorless and tasteless. Swells in water to form a clear or slightly cloudy colloidal solution but is nearly insoluble in hot water or ethanol. Prepared by dispersing in hot water and dissolving upon cooling. |
Polyvinylpyrrolidone (PVP) | Available in various molecular weights (e.g., K30, K60, K90). K30 is most common, a white or off-white powder, odorless or with a faint odor, and hygroscopic. Soluble in water and ethanol. Used as a binder in aqueous or alcohol solutions. |
Disintegrants | Description |
Dry Starch | A classic disintegrant dried at 100-105°C to below 8% moisture content. Strongly hygroscopic, with a water absorption expansion rate of ~186%. Suitable for poorly soluble or slightly soluble drugs but less effective for soluble drugs. |
Sodium Carboxymethyl Starch | Sodium salt of carboxylic ether of starch. Insoluble in water but exhibits significant water absorption and swelling (~300 times its original volume), making it a super disintegrant. |
Crosslinked Sodium Carboxymethyl Cellulose | Insoluble in water, swells 4-8 times its volume upon absorption. Excellent disintegrant, often combined with sodium carboxymethyl starch for enhanced effects. |
Crosslinked Polyvinylpyrrolidone | Insoluble in water but exhibits rapid capillary action and maximum water absorption of ~60%, with an expansion ratio of 2.25-2.3, also classified as a super disintegrant. |
Lubricants | Description |
Magnesium Stearate | White powder with hydrophobicity, smooth to the touch. Easily mixed and adheres to material surfaces to reduce friction between material and die. Typical use is 0.1-1%, but excessive use may prolong tablet disintegration time. |
Talc | White or grayish-white crystalline powder with a soft touch. Typically used at 0.1-3%. |
Colloidal Silicon Dioxide | White powder with a large specific surface area. Typically used at 0.1-0.3%. |
With the rise of personalized and precision medicine, the effectiveness and safety of drugs are increasingly dependent on the precise design of excipients. Pharmaceutical excipients not only help improve the stability, solubility, and bioavailability of drugs but also enhance drug release control and dosage form innovation. In new drug delivery systems such as nanomedicines, controlled-release formulations, and targeted drug delivery, the role of excipients is particularly prominent. Additionally, with the rapid development of biopharmaceuticals and biotechnology drugs, there is a growing demand for high-performance, low-toxicity excipients. The development of pharmaceutical excipients is gradually moving towards a greener and more sustainable direction, with natural-derived and biodegradable excipients receiving increasing attention.
** Recommended Products **
Name | CAS | Catalog | Price |
L-Glutamine | 56-85-9 | BAT-014317 | Inquiry |
L-Histidine | 71-00-1 | BAT-014306 | Inquiry |
L-Tryptophan | 73-22-3 | BAT-014312 | Inquiry |
L-Glutamic acid | 56-86-0 | BAT-014298 | Inquiry |
L-(+)-Arginine | 74-79-3 | BAT-014316 | Inquiry |
L-Cysteine Hydrochloride | 52-89-1 | BAT-008076 | Inquiry |
L-Glutamic Acid Hydrochloride | 138-15-8 | BAT-004723 | Inquiry |
L-Tyrosine hydrochloride | 16870-43-2 | BAT-004042 | Inquiry |
L-Phenylalanine | 63-91-2 | BAT-014318 | Inquiry |
L-Valine | 72-18-4 | BAT-014314 | Inquiry |
L-Leucine | 61-90-5 | BAT-014308 | Inquiry |
L-Aspartic acid | 56-84-8 | BAT-014297 | Inquiry |
L-lysine | 56-87-1 | BAT-014299 | Inquiry |
L-Serine | 56-45-1 | BAT-014301 | Inquiry |